The global market for RSV Vaccine was estimated to be worth US$ 162 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030

RSV Vaccine - Market

Respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which prevents infection by respiratory syncytial virus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RSV Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of RSV Vaccine by region & country, by Type, and by Application.

The RSV Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Vaccine.

Market Segmentation

Scope of RSV Vaccine - Market Report

Report Metric	Details
Report Name	RSV Vaccine - Market
Forecasted market size in 2030	US$ 261 million
CAGR	7.3%
Forecasted years	2024 - 2030
Segment by Type:	Clinical I Clinical II Clinical III Preclinical Being Developed
Segment by Application	Elderly Vaccine Infant Vaccine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma, Advaccine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of RSV Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of RSV Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the RSV Vaccine - Market size in 2030?

Ans: The RSV Vaccine - Market size in 2030 will be US$ 261 million.

Who are the main players in the RSV Vaccine - Market report?

Ans: The main players in the RSV Vaccine - Market are Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma, Advaccine

What are the Application segmentation covered in the RSV Vaccine - Market report?

Ans: The Applications covered in the RSV Vaccine - Market report are Elderly Vaccine, Infant Vaccine, Others

What are the Type segmentation covered in the RSV Vaccine - Market report?

Ans: The Types covered in the RSV Vaccine - Market report are Clinical I, Clinical II, Clinical III, Preclinical, Being Developed

1 Market Overview

1.1 RSV Vaccine Product Introduction

1.2 Global RSV Vaccine Market Size Forecast

1.2.1 Global RSV Vaccine Sales Value (2019-2030)

1.2.2 Global RSV Vaccine Sales Volume (2019-2030)

1.2.3 Global RSV Vaccine Sales Price (2019-2030)

1.3 RSV Vaccine Market Trends & Drivers

1.3.1 RSV Vaccine Industry Trends

1.3.2 RSV Vaccine Market Drivers & Opportunity

1.3.3 RSV Vaccine Market Challenges

1.3.4 RSV Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global RSV Vaccine Players Revenue Ranking (2023)

2.2 Global RSV Vaccine Revenue by Company (2019-2024)

2.3 Global RSV Vaccine Players Sales Volume Ranking (2023)

2.4 Global RSV Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global RSV Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers RSV Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers RSV Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of RSV Vaccine

2.9 RSV Vaccine Market Competitive Analysis

2.9.1 RSV Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by RSV Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Clinical I

3.1.2 Clinical II

3.1.3 Clinical III

3.1.4 Preclinical

3.1.5 Being Developed

3.2 Global RSV Vaccine Sales Value by Type

3.2.1 Global RSV Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global RSV Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global RSV Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global RSV Vaccine Sales Volume by Type

3.3.1 Global RSV Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global RSV Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global RSV Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global RSV Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Elderly Vaccine

4.1.2 Infant Vaccine

4.1.3 Others

4.2 Global RSV Vaccine Sales Value by Application

4.2.1 Global RSV Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global RSV Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global RSV Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global RSV Vaccine Sales Volume by Application

4.3.1 Global RSV Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global RSV Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global RSV Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global RSV Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global RSV Vaccine Sales Value by Region

5.1.1 Global RSV Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global RSV Vaccine Sales Value by Region (2019-2024)

5.1.3 Global RSV Vaccine Sales Value by Region (2025-2030)

5.1.4 Global RSV Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global RSV Vaccine Sales Volume by Region

5.2.1 Global RSV Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global RSV Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global RSV Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global RSV Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global RSV Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America RSV Vaccine Sales Value, 2019-2030

5.4.2 North America RSV Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe RSV Vaccine Sales Value, 2019-2030

5.5.2 Europe RSV Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific RSV Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific RSV Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America RSV Vaccine Sales Value, 2019-2030

5.7.2 South America RSV Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa RSV Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa RSV Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions RSV Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions RSV Vaccine Sales Value

6.2.1 Key Countries/Regions RSV Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions RSV Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States RSV Vaccine Sales Value, 2019-2030

6.3.2 United States RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States RSV Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe RSV Vaccine Sales Value, 2019-2030

6.4.2 Europe RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe RSV Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China RSV Vaccine Sales Value, 2019-2030

6.5.2 China RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China RSV Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan RSV Vaccine Sales Value, 2019-2030

6.6.2 Japan RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan RSV Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea RSV Vaccine Sales Value, 2019-2030

6.7.2 South Korea RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea RSV Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia RSV Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia RSV Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India RSV Vaccine Sales Value, 2019-2030

6.9.2 India RSV Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India RSV Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Company Information

7.1.2 Pfizer Introduction and Business Overview

7.1.3 Pfizer RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Pfizer RSV Vaccine Product Offerings

7.1.5 Pfizer Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK RSV Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Moderna

7.3.1 Moderna Company Information

7.3.2 Moderna Introduction and Business Overview

7.3.3 Moderna RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Moderna RSV Vaccine Product Offerings

7.3.5 Moderna Recent Development

7.4 JNJ

7.4.1 JNJ Company Information

7.4.2 JNJ Introduction and Business Overview

7.4.3 JNJ RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 JNJ RSV Vaccine Product Offerings

7.4.5 JNJ Recent Development

7.5 Bavarian Nordic

7.5.1 Bavarian Nordic Company Information

7.5.2 Bavarian Nordic Introduction and Business Overview

7.5.3 Bavarian Nordic RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bavarian Nordic RSV Vaccine Product Offerings

7.5.5 Bavarian Nordic Recent Development

7.6 Nuance Pharma

7.6.1 Nuance Pharma Company Information

7.6.2 Nuance Pharma Introduction and Business Overview

7.6.3 Nuance Pharma RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Nuance Pharma RSV Vaccine Product Offerings

7.6.5 Nuance Pharma Recent Development

7.7 Advaccine

7.7.1 Advaccine Company Information

7.7.2 Advaccine Introduction and Business Overview

7.7.3 Advaccine RSV Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Advaccine RSV Vaccine Product Offerings

7.7.5 Advaccine Recent Development

8 Industry Chain Analysis

8.1 RSV Vaccine Industrial Chain

8.2 RSV Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 RSV Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 RSV Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. RSV Vaccine Market Trends

Table 2. RSV Vaccine Market Drivers & Opportunity

Table 3. RSV Vaccine Market Challenges

Table 4. RSV Vaccine Market Restraints

Table 5. Global RSV Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global RSV Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global RSV Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global RSV Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market RSV Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers RSV Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers RSV Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of RSV Vaccine

Table 13. Global RSV Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global RSV Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global RSV Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global RSV Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global RSV Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global RSV Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global RSV Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global RSV Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global RSV Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global RSV Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global RSV Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global RSV Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global RSV Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global RSV Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global RSV Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global RSV Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global RSV Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global RSV Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global RSV Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global RSV Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global RSV Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global RSV Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global RSV Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global RSV Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global RSV Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global RSV Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global RSV Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global RSV Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global RSV Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global RSV Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global RSV Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global RSV Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global RSV Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global RSV Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global RSV Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global RSV Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global RSV Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions RSV Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions RSV Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions RSV Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions RSV Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions RSV Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Pfizer RSV Vaccine Product Offerings

Table 61. Pfizer Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. GSK RSV Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Moderna Company Information

Table 68. Moderna Introduction and Business Overview

Table 69. Moderna RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Moderna RSV Vaccine Product Offerings

Table 71. Moderna Recent Development

Table 72. JNJ Company Information

Table 73. JNJ Introduction and Business Overview

Table 74. JNJ RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. JNJ RSV Vaccine Product Offerings

Table 76. JNJ Recent Development

Table 77. Bavarian Nordic Company Information

Table 78. Bavarian Nordic Introduction and Business Overview

Table 79. Bavarian Nordic RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Bavarian Nordic RSV Vaccine Product Offerings

Table 81. Bavarian Nordic Recent Development

Table 82. Nuance Pharma Company Information

Table 83. Nuance Pharma Introduction and Business Overview

Table 84. Nuance Pharma RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Nuance Pharma RSV Vaccine Product Offerings

Table 86. Nuance Pharma Recent Development

Table 87. Advaccine Company Information

Table 88. Advaccine Introduction and Business Overview

Table 89. Advaccine RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Advaccine RSV Vaccine Product Offerings

Table 91. Advaccine Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. RSV Vaccine Downstream Customers

Table 95. RSV Vaccine Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. RSV Vaccine Product Picture

Figure 2. Global RSV Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global RSV Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global RSV Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. RSV Vaccine Report Years Considered

Figure 7. Global RSV Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global RSV Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by RSV Vaccine Revenue in 2023

Figure 10. RSV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Clinical I Picture

Figure 12. Clinical II Picture

Figure 13. Clinical III Picture

Figure 14. Preclinical Picture

Figure 15. Being Developed Picture

Figure 16. Global RSV Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global RSV Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global RSV Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global RSV Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global RSV Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Elderly Vaccine

Figure 22. Product Picture of Infant Vaccine

Figure 23. Product Picture of Others

Figure 24. Global RSV Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global RSV Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global RSV Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global RSV Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global RSV Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. North America RSV Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe RSV Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific RSV Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. South America RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 36. South America RSV Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa RSV Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa RSV Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions RSV Vaccine Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions RSV Vaccine Sales Volume (%), (2019-2030)

Figure 41. United States RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. United States RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. China RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. China RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. China RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 59. India RSV Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 60. India RSV Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 61. India RSV Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 62. RSV Vaccine Industrial Chain

Figure 63. RSV Vaccine Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions